The project aims at keeping as active as possible, socially and at work, people ageing with chronic conditions with disabling symptoms, as tremor that has a significant impact on the life of patients. Combining advanced technologies with design principles, we will develop a
wearable device which can monitor the movement of the upper limbs and, through an ad-hoc algorithm based on machine learning, can recognize tremor and to suppress it. The project includes an in-depth analysis to understand the user’s attitudes and preferences, a clinical trial aimed at optimizing the technology, and the technological development activities. The goal is to create a non-invasive and non-stigmatizing device that could be worn proudly or discretely, according to the user’s attitude.

We also aim to increase patient’s awareness: our website could become a landmark for patients and caregivers for the disease education and to be ever updated with our discoveries. The app connecting JAME to patients will become a way for the doctor to monitor the disease progress, and to adjust its treatment, but also a way for Jame itself to improve its effectiveness.


Jame wants to improve the quality of life of people ageing with chronic conditions, by integrating technology and design principles to alleviate symptoms; we mainly target hand tremor that has a significant impact especially in Parkinson’s disease. We propose a cool looking wearable device that is able both to identify and control hand tremor and to overcome the classical barriers of poor usability and acceptability of medical devices, due to their high stigmatizing nature. JAME is designed to help the patient act “normally”
thanks to the synergy between wearable sensors and artificial intelligence.

Expected Results and Impact:

The main expected result is the development of a device aimed at controlling disabling symptoms in patients with chronic conditions, able to overcome the classical barriers of poor usability and acceptability due to the highly stigmatizing nature of currently available
devices. Jame is expected to allow a user to become autonomous and to interact with people without feeling embarrassed of his/her own disease. After the end of the project, we expect to reach the market in 2 years.


Partners involved in the project

Organization Type Country Website
Università degli Studi di Trieste R&D Italy www.dia.units.it/
Feature Jam SME Italy www.featurejam.com
Foundation for the Study of Neuroprotection and Neuroplasticity R&D Romania www.roneuro.ro
Fundación de investigación HM Hospitales R&D Spain www.fundac ionhm.com/
BOONE End-User Belgium www.boone. be
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico R&D Italy www.policlinico.mi.it
  • Project name: Combining biomedical technologies and design to control disabling symptoms in
    ageing people with chronic neurodegenerative diseases (JAME)
  • Website: https://jame.units.it
  • Coordinator: Università degli Studi di Trieste
  • Duration: 9 months
  • Starting date: 03/2020
  • Total budget: € 337,774
  • Public contribution: € 275,2438


Sara Renata Francesca Marceglia

E.: smarceglia@units.it

T.: +39 040 5583450

This website use cookies. By browsing our site you agree to our use of cookies Read moreAccept